ALKERMES | ALKS - Rentabilidad Por Dividendo





Dy Cambio Fecha
AbbVie 2.91 0.58 2025-12
Amgen 2.95 0.38 2025-12
Bristol-Myers Squibb 0.22 0.04 2025-12
Coherus Biosciences 0 0 2025-03
Eli Lilly 0.58 0.16 2025-12
Gilead Sciences 2.58 0.25 2025-12
Heron Therapeutics 0 0 2025-03
J&J 2.5 0.32 2025-12
Merck 3.12 0.74 2025-12
Minerva Neurosciences 0 0 2025-03
Nektar Therapeutics 0 0 2025-03
Otsuka Holdings 1.46 0.19 2025-12
Ovoca Bio EUR 0 0 2024-12
Pfizer 6.91 0.33 2025-12
Regeneron Pharmaceuticals 0.46 0.01 2025-12